---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-272368"
form_type: "8-K"
ticker: "RKDA"
cik: "0001469443"
company_name: "Arcadia Biosciences, Inc."
filed_at: "2025-11-07T23:59:59+00:00"
generated_at: "2026-05-16T23:01:27.902317+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Arcadia Q3 net income $856k vs loss $1.6M YoY; Zola YTD revenue up 26%

## Summary
- Q3 total revenue $1.30M, down 15% YoY; loss from operations $1.15M.
- Net income attributable to common $856k ($0.63 diluted EPS) vs loss $1.61M ($1.18 loss) in Q3 2024.
- Zola coconut water YTD revenue up 26% YoY; gross margin >30% for 11th straight quarter.
- Cash balance $1.12M at Sept 30, 2025; pending Roosevelt Resources combination delayed by federal shutdown.
- Recognized $4.7M credit loss on Above Food note; holds 2.7M ABVE shares valued at $3.07M.

## SEC filing metadata
- accession: 0001193125-25-272368
- form_type: 8-K
- ticker: RKDA
- cik: 0001469443
- company_name: Arcadia Biosciences, Inc.
- filed_at: 2025-11-07T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1469443/000119312525272368/0001193125-25-272368-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1469443/000119312525272368/rkda-20251107.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-272368
- JSON: https://secwatch.observer/filing/0001193125-25-272368.json
- Plain text: https://secwatch.observer/filing/0001193125-25-272368.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.